Lazar David E.'s Form 4/A amendment
AmendedTitan Pharmaceuticals Inc (TTNP) · filed Jun 28, 2023
- Accession no.
- 0000921895-23-001593
- Filed
- Jun 28, 2023, 4:14 PM ET
- Trade date
- Jun 21, 2023
- Filing delay
- 7 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jun 23, 2023
This filing lists 2 non-derivative transactions. Open-market sales total $4.61M. It was filed 7 days after the trade.
This amendment replaces 0000921895-23-001569 (filed Jun 23, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lazar David E.CIK 0001932843 | Director, Officer (Chief Executive Officer), 10% Owner |
| Activist Investing LLCCIK 0001817604 | Other: Member of 10% owner group |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
These Shares were sold pursuant to a Share Transfer Agreement dated June 21, 2023. As consideration for the transfer, Mr. Lazar received $4,600,000.
Referenced by the price of 2 transactions in Table I.
- F2
Prior to the filing of the Reporting Persons's Form 4 on June 23, 2023, the Reporting Person contacted the Issuer and advised the Issuer of his obligation to disgorge the "short-swing profit" realized by the Reporting Person, and that he was making preparation for payment of such disgorgement. Due to a ministerial error, such informaton was inadvertently excluded from the Form 4 filed by the Reporting Person on June 23, 2023.
Referenced by the price of 2 transactions in Table I.
- F3
This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
- F4
Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
- F5
Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.